Department of Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Hepatocellular Carcinoma 84%
3. Urinary Bladder Neoplasms 46%
4. Hepatitis B virus 45%
5. Liver 42%
6. Colorectal Neoplasms 39%
7. Carcinoma 39%
8. Lymphoma, Large B-Cell, Diffuse 38%
9. Carcinogenesis 37%
10. Survival 35%
11. Transitional Cell Carcinoma 34%
12. ErbB Receptors 33%
13. Chronic Hepatitis B 31%
14. Mutation 28%
15. T-Cell Lymphoma 28%
16. Helicobacter pylori 25%
17. Therapeutics 24%
18. Urinary Bladder 24%
19. Genes 21%
20. Serum 21%
21. Membrane Proteins 21%
22. Lymphoma 20%
23. Growth 20%
24. Urinary Tract 18%
25. Drug Therapy 17%
26. Metaplasia 17%
27. rice bran saccharide 17%
28. Urine 16%
29. Non-Small Cell Lung Carcinoma 16%
30. DNA 16%
31. Stomach 16%
32. Nasopharyngeal Carcinoma 15%
33. Pylorus 15%
34. Biomarkers 15%
35. Endoplasmic Reticulum Stress 15%
36. Adenocarcinoma 15%
37. Cell Line 15%
38. Proteins 15%
39. Vascular Endothelial Growth Factor A 14%
40. Squamous Cell Carcinoma 14%
41. Glass 14%
42. Staining and Labeling 14%
43. Lung 13%
44. Hepatitis B Surface Antigens 13%
45. Biopsy 13%
46. Methotrexate 13%
47. Oncogene Proteins 12%
48. Immunoglobulin G 12%
49. Lymphadenopathy 12%
50. In Vitro Techniques 12%
51. Microsatellite Repeats 12%
52. Inflammation 11%
53. spasmolytic polypeptide 11%
54. Osteopontin 11%
55. Electromagnetic Phenomena 11%
56. B-Lymphocytes 11%
57. Pancreatic Neoplasms 11%
58. Loss of Heterozygosity 11%
59. Isoflavones 11%
60. Surface Antigens 11%
61. Lymphocytes 11%
62. Immunohistochemistry 11%
63. High-Throughput Nucleotide Sequencing 11%
64. Hemophagocytic Lymphohistiocytosis 11%
65. Stomach Neoplasms 11%
66. Cell Proliferation 11%
67. Peripherins 10%
68. Pterygium 10%
69. interleukin 20 10%
70. Hepatitis B e Antigens 10%
71. Systemic Lupus Erythematosus 10%
72. Hydroa Vacciniforme 10%
73. TOR Serine-Threonine Kinases 10%
74. tissue polypeptide specific antigen 10%
75. Cytogenetics 10%
76. T-Lymphocytes 10%
77. Skin 10%
78. Gastrointestinal Stromal Tumors 10%
79. Catenins 10%
80. Epidermal Growth Factor 9%
81. Mouth Neoplasms 9%
82. Verrucous Carcinoma 9%
83. Adenoma 9%
84. Macrophages 9%
85. Lung Neoplasms 9%
86. Thymic epithelial tumor 9%